Enrico Colli, MD
Chemo Research SL · Chemo Research · Exeltis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Enrico Colli, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06968481 · Sublingual Oxytocin for the Prevention of Post-partum HemorrhageInsud Pharma · not yet recruiting · Post Partum Hemorrhage · study director
- Ph3NCT05461573 · Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in FemalesInsud Pharma · completed · Contraception, Change in Bone Mineral Density · study director
- Ph4NCT05303636 · LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult WomenInsud Pharma · active not recruiting · Change in Bone Mineral Density, Bone Loss · study director
- Ph3NCT03945513 · A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 CyclesInsud Pharma · completed · Contraception · study director
- Ph3NCT02269241 · Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 CyclesLaboratories Leon Farma, S.A. · completed · Contraception · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.